fundregtracker.
Last verified 2026-10-12

OrbiMed — funds, providers and filings

Managers: all tracked managers · fund search & entity graph · private market performance

Registrations

  • 2026-05-22 New fund vehicle registered: OrbiMed Asia Partners IV, L.P. (KY) entity register
  • 2026-05-22 New fund vehicle registered: OrbiMed Private Investments VIII, LP (US-DE) entity register
  • 2026-05-12 New fund vehicle registered: ORBIMED PRIVATE INVESTMENTS X, LP (US-DE) entity register
  • 2026-05-12 New fund vehicle registered: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V OFFSHORE, LP (US-DE) entity register
  • 2026-05-12 New fund vehicle registered: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP (US-DE) entity register
Assets
Assets under management$20bn OrbiMed, in 2026
Of that, the part reported to the US SEC as private funds$18.2bn gross · 31 funds Form ADV, through 2024
Activity sources: this site's news archive (tracked since July 2026) · the manager's own newsroom · the worldwide entity register (registration dates as the register records them).

OrbiMed is a healthcare-focused investment firm. It invests worldwide, from start-ups to large companies. It runs private equity, public equity, and royalty and credit funds across the health industry. (OrbiMed)

Asset classes

The range spans healthcare public equity, private equity and royalty and credit.

Assets, investors and structure above are built from public sources — the worldwide entity register and the manager's own reports. Every figure carries its source's own date · OrbiMed official site.
A profile built from public sources — SEC Form ADV (filings through 2024), the worldwide entity register, the manager's own reports and this site's own news coverage. Figures carry each source's own dates.

Fund structure

Its funds are organised into 1 feeder funds.

The US-reported view

The sections below draw on US regulatory filings — SEC Form ADV and Form D — and on US investors' own disclosures. They set out OrbiMed's US-reported slice: the funds, service providers, domiciles and activity visible in US filings, not its worldwide business.

1. US-SEC private funds

This page reports $18.2bn of gross asset value across 31 private funds that OrbiMed reports on SEC Form ADV, filings through 2024. Its firm-wide figures are in the Assets summary at the top of this page, measured on a different basis.

Worldwide, 9 registered fund vehicles are on file under its management companies, on the worldwide entity register (read 2026-10-05) — these are legal fund entities, not the share classes or products a manager markets.

Registered fund vehicles worldwide (as at 2026-10-05)9
Management entities on file (US filings · worldwide register)2 · 1
Principal offices on fileNew York, United States
The gross asset value above is the SEC-reported private funds only, as filed — a narrower, verifiable subset of a manager's firm-wide AUM, which is stated on its own basis and can include separate accounts, committed-but-uncalled capital and vehicles outside US SEC reporting. The two are different measures and will not match.

2. Service providers

KPMG audits 30 of the 31 OrbiMed funds that name an auditor on Form ADV Schedule D, filings through 2024 — more than any other firm. SS&C administers 17 of the 27 that name an administrator, on the same filings. Relationships the filings attribute to OrbiMed's own group are part of its structure, not third-party appointments, and are left out of these counts.

Across the funds that disclose each role on Schedule D — the count is funds naming that provider, of funds disclosing the role at all:

Fund administratorSS&C (17 of 27); Hedgeserv (Cayman) LTD. (10 of 27)
AuditorKPMG (30 of 31); Brightman Almagor Zohar & Co. (2 of 31)
CustodianJ.P. Morgan (24 of 31); Silicon Valley Bank (22 of 31); Merrill Lynch (10 of 31) — and 15 more
Prime brokerGoldman Sachs (7 of 5); J.P. Morgan (5 of 5)
Marketer / placementFar Hills Group, LLC. (5 of 10); J.P. Morgan (5 of 10); Wells Fargo (2 of 10) — and 1 more
Source: SEC Form ADV Schedule D 7.B.(1), filings through 2024. The top three per role are shown; the full lists are available on request: [email protected]. Provider names are rolled up to their group brand where the rollup is unambiguous; otherwise they appear as filed.

3. Fund domiciles

18 of OrbiMed's 31 SEC-reported private funds are domiciled in Delaware, its largest single domicile on Form ADV, filings through 2024. Cayman Islands is next, and the bars below give the rest in order.

Delaware18
Cayman Islands10
Bermuda1
Israel1
Luxembourg1

4. Fund filing activity

OrbiMed Private Investments X, LP is the largest US raise on file for an OrbiMed fund: $1.7bn sold to date, on its 2026 Form D filing. Amounts are cumulative sold-to-date figures as filed. They cover a fund's life up to that filing, not a single fundraise, and a fund that raises outside the US files nothing here.

The largest of the 3 US private-fund filings for OrbiMed's funds, by amount sold to date as filed.

IssuerTypeAmount sold (as filed)Filing yearSource
OrbiMed Private Investments X, LPPrivate Equity Fund$1.7bn2026filing
OrbiMed Asia Partners VI, L.P.Private Equity Fund$534m2026filing
OrbiMed Genesis Fund, Ltd.Hedge Fund$146m2026filing
Source: SEC EDGAR Form D (public filings; amounts are cumulative "sold to date" figures as filed, not fundraise announcements).

5. Fund performance

Every figure here is a disclosing pension plan's own, on that plan's own reporting date. Nothing is blended into a manager-level return, because no plan published one.

Per-fund net IRR, multiple and DPI as disclosed by the pension plans invested in the funds — the LPs' own numbers, on their own dates, not the manager's. One row per plan disclosure. Where two plans hold the same fund and report different numbers, both rows show, with their dates:

FundPlanNet IRRMultipleDPIReported as atSource
OrbiMed Royalty Credit Opps VCalSTRS0.0%——30 June 2025CalSTRS private equity performance report
OrbiMed Private Investments IX LPCalSTRS24.1%1.260.2830 June 2025CalSTRS private equity performance report
OrbiMed Royalty Credit Opps IVCalSTRS13.2%1.110.5830 June 2025CalSTRS private equity performance report
OrbiMed Private Investments VIII LPCalSTRS6.9%1.190.330 June 2025CalSTRS private equity performance report
OrbiMed Royalty & Credit Opportunities III, LPCalSTRS15.1%1.20.9530 June 2025CalSTRS private equity performance report
OrbiMed Private Investments VIOregon OPERF14.1%1.761.2231 March 2026Oregon Treasury OPERF private equity portfolio
OrbiMed Private Investments VCalSTRS38.2%2.452.2530 June 2025CalSTRS private equity performance report
OrbiMed Private Investments VOregon OPERF38.2%2.382.1431 March 2026Oregon Treasury OPERF private equity portfolio
OrbiMed Private Investments IV, L.P.CalSTRS31.8%3.123.0530 June 2025CalSTRS private equity performance report
OrbiMed Private Investments IV, L.P.Oregon OPERF31.8%2.732.7331 March 2026Oregon Treasury OPERF private equity portfolio

Young vintages sit in the J-curve: an early negative IRR mostly reflects fees drawn before value is realised, and is not a verdict on the fund.

6. Known LP investors, from their own disclosures

CalSTRS (7), Oregon OPERF (3) — the count is this manager's funds appearing in that plan's disclosure.

Source: each pension plan's own published performance disclosure, as compiled on this site (per-plan as-at dates shown in the table). Net IRR and multiple are taken exactly as each plan reported them; DPI is distributions ÷ contributions from the plan's own cash-flow columns. Coverage is limited to the pension plans this site follows — a fund without such an investor does not appear here, and that absence says nothing about the fund.

7. Management entities

OrbiMed files Form ADV through 2 management entities; the largest is Orbimed Advisors LLC, CRD 118608 of New York, with 30 of the 31 funds on this page. Every figure above rolls those filers up into one business. The table below traces each of them back to the entity that filed it, so a number can be checked against its own record rather than taken on trust.

US management entities on file (2 entities — together the 31 funds above)
EntitySEC CRDCity Funds of the 31
Orbimed Advisors LLCCRD 118608New York30
Orbimed Capital LLCCRD 120188New York1
Management entities on the worldwide register (1 entities — together the 9 registered vehicles)
EntityRegister IDFund vehicles
Orbimed Advisors LLC57G4FX4JA0RP0CHYJ7829

Questions this page answers

What is OrbiMed's AUM?

Across the group it managed $20 billion in 2026. (OrbiMed). It also reports $18.2bn of gross asset value across 31 private funds on its US SEC filings (Form ADV, through 2024).

Who audits OrbiMed's funds?

KPMG is named on 30 of the 31 US private funds whose filing discloses an auditor on Form ADV Schedule D (of OrbiMed's 31 filed with the SEC), filings through 2024. Brightman Almagor Zohar & Co. appears on 2 of the same filings.

Who administers OrbiMed's funds?

SS&C is named on 17 of the 27 US private funds whose filing discloses an administrator on Form ADV Schedule D (of OrbiMed's 31 filed with the SEC), filings through 2024. Hedgeserv (Cayman) LTD. appears on 10 of the same filings.

How have OrbiMed's funds performed?

OrbiMed Private Investments IV, L.P. returned a net IRR of 31.8% on a 2.73 multiple, as Oregon OPERF reported it for 31 March 2026. OrbiMed Private Investments V returned a net IRR of 38.2% on a 2.38 multiple, as Oregon OPERF reported it for 31 March 2026.

Who invests in OrbiMed's funds?

CalSTRS (7 funds) and Oregon OPERF (3 funds) name OrbiMed funds in their published disclosures. Coverage is limited to the plans this site follows, and a plan's absence says nothing about whether it invests.

How many funds does OrbiMed run?

OrbiMed has 9 registered fund vehicles on the worldwide entity register — legal fund entities, not the share classes or products a manager markets. Separately, it reports 31 private funds to the US SEC (Form ADV, through 2024) — a different register, counted on a different basis.

Where are OrbiMed's funds domiciled?

18 of the 31 funds are domiciled in Delaware, its largest single domicile on Form ADV, filings through 2024, followed by Cayman Islands with 10.

Where does OrbiMed file from?

Orbimed Advisors LLC, CRD 118608, its largest Form ADV filer, gives its office as New York, United States. The other filers' offices are in the entity table on this page.

Is OrbiMed registered with the SEC?

Yes. Its filings run through 2 management entities, the largest being Orbimed Advisors LLC, CRD 118608, with 30 of the 31 funds here.

Sources: SEC Form ADV (public filings; figures as filed, through 2024) · global entity register (GLEIF, read 2026-10-05) · this site's news archive. Corrections: how to request one. The full data behind any table on this page is available on request: [email protected].

See also: all tracked managers · fund search & entity graph.

↑ Top